Ask AI
CAR T Cell and Bispecific Antibodies in Multiple Myeloma
Combating Myeloma: Improving Access and Outcomes With CAR T-Cell and Bispecific Antibody Therapies in Veterans With Relapsed/Refractory Multiple Myeloma

Released: September 25, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: September 25, 2025